This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Aug;9(8):443.

doi: 10.1038/nrrheum.2013.102. Epub 2013 Jun 25.

Lupus nephritis: a rituximab-based regimen might enable oral steroid avoidance in lupus nephritis

PMID: 23797310
DOI: 10.1038/nrrheum.2013.102

Comment

Lupus nephritis: a rituximab-based regimen might enable oral steroid avoidance in lupus nephritis

David Killock. Nat Rev Rheumatol. 2013 Aug.

. 2013 Aug;9(8):443.

doi: 10.1038/nrrheum.2013.102. Epub 2013 Jun 25.

Author

PMID: 23797310
DOI: 10.1038/nrrheum.2013.102

No abstract available

PubMed Disclaimer

Comment on

Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
Condon MB, Ashby D, Pepper RJ, Cook HT, Levy JB, Griffith M, Cairns TD, Lightstone L. Condon MB, et al. Ann Rheum Dis. 2013 Aug;72(8):1280-6. doi: 10.1136/annrheumdis-2012-202844. Epub 2013 Jun 5. Ann Rheum Dis. 2013. PMID: 23740227 Clinical Trial.

References

1. Ann Rheum Dis. 2013 Aug;72(8):1280-6 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations